Gossamer Bio, Inc. - Common Stock (GOSS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
GOSS on Nasdaq
Shares outstanding
231,780,123
Price per share
$3.10
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
180,099,073
Total reported value
$473,650,324
% of total 13F portfolios
0%
Share change
+2,781,367
Value change
+$14,481,579
Number of holders
161
Price from insider filings
$3.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Gossamer Bio, Inc. - Common Stock (GOSS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Octagon Capital Advisors LP 8.6% $17,226,928 19,576,054 Octagon Capital Advisors LP 31 Dec 2024
BlackRock, Inc. 6.5% +24% $46,705,201 +$9,084,437 15,065,708 +24% BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 5% +15% $14,035,274 +$1,693,271 11,410,792 +14% The Vanguard Group 30 Jun 2025
Invus Global Management, LLC 2.8% $5,507,814 6,258,880 Invus Public Equities, L.P. 31 Dec 2024

As of 30 Sep 2025, 161 institutional investors reported holding 180,099,073 shares of Gossamer Bio, Inc. - Common Stock (GOSS). This represents 78% of the company’s total 231,780,123 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Gossamer Bio, Inc. - Common Stock (GOSS) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
NEA Management Company, LLC 7.8% 18,093,034 0% 2.6% $47,584,679
Octagon Capital Advisors LP 7.4% 17,050,000 -7.1% 7% $44,841,500
BlackRock, Inc. 6% 13,846,054 +14% 0% $36,415,120
VANGUARD GROUP INC 5.2% 12,009,773 +5.2% 0% $31,585,704
ARCH Venture Management, LLC 3.5% 8,055,916 0% 4.3% $21,187,059
SAMSARA BIOCAPITAL, LLC 2.6% 6,130,268 0% 2.1% $16,122,605
Palo Alto Investors LP 2.4% 5,464,349 -4.8% 2.7% $14,371,238
Siren, L.L.C. 2.2% 5,208,968 0% 0.54% $13,699,586
683 Capital Management, LLC 2.2% 5,059,200 -20% 1.2% $13,305,696
ACADIAN ASSET MANAGEMENT LLC 2.2% 5,012,969 -30% 0.02% $13,181,000
HHLR ADVISORS, LTD. 2.1% 4,974,041 0% 0.32% $13,081,728
SILVERARC CAPITAL MANAGEMENT, LLC 2.1% 4,779,082 -7.1% 1.8% $12,568,986
GEODE CAPITAL MANAGEMENT, LLC 2% 4,689,531 +3% 0% $12,335,807
FMR LLC 1.8% 4,085,346 -44% 0% $10,744,459
STATE STREET CORP 1.7% 3,883,667 +57% 0% $10,214,044
PERCEPTIVE ADVISORS LLC 1.6% 3,812,797 0.29% $10,027,656
MILLENNIUM MANAGEMENT LLC 1.6% 3,619,329 +629% 0.01% $9,518,835
Rock Springs Capital Management LP 1.4% 3,266,960 0% 0.5% $8,592,105
RENAISSANCE TECHNOLOGIES LLC 1.3% 2,980,188 +9.1% 0.01% $7,837,894
BANK OF AMERICA CORP /DE/ 1.2% 2,881,904 +4196% 0% $7,579,408
UBS Group AG 1.2% 2,770,046 +786% 0% $7,285,221
Opaleye Management Inc. 1.2% 2,725,000 -23% 1% $7,166,750
TWO SIGMA INVESTMENTS, LP 0.99% 2,287,251 +31% 0.01% $6,015,470
CITADEL ADVISORS LLC 0.99% 2,284,216 +198% 0% $6,007,488
Alyeska Investment Group, L.P. 0.82% 1,909,087 -57% 0.02% $5,020,899

Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 799,497 $2,459,500 +$2,224,703 $3.10 10
2025 Q3 180,099,073 $473,650,324 +$14,481,579 $2.63 161
2025 Q2 177,241,575 $218,003,209 +$9,779,866 $1.23 123
2025 Q1 169,972,743 $186,887,807 -$1,268,144 $1.10 118
2024 Q4 171,313,829 $154,975,691 -$4,643,111 $0.90 102
2024 Q3 174,874,615 $172,644,460 -$19,949,532 $0.99 99
2024 Q2 182,850,284 $164,736,451 -$20,026,799 $0.90 93
2024 Q1 197,765,806 $233,516,476 -$11,193,563 $1.18 105
2023 Q4 203,270,485 $185,471,165 +$4,883,709 $0.91 96
2023 Q3 205,596,440 $171,215,346 +$117,834,337 $0.83 93
2023 Q2 62,010,889 $74,414,154 -$19,164,753 $1.20 94
2023 Q1 77,679,537 $97,875,805 -$40,109,226 $1.26 107
2022 Q4 103,773,723 $225,185,263 -$165,052,760 $2.17 117
2022 Q3 85,232,624 $1,021,045,667 +$262,239,455 $11.98 154
2022 Q2 63,691,207 $533,207,849 +$32,485,845 $8.37 126
2022 Q1 59,875,031 $519,727,258 +$5,179,881 $8.68 138
2021 Q4 58,810,100 $664,847,746 +$43,218,257 $11.31 129
2021 Q3 54,748,025 $687,740,924 +$24,001,097 $12.57 123
2021 Q2 53,088,201 $431,075,177 -$10,198,257 $8.12 109
2021 Q1 54,256,286 $501,857,885 +$8,880,956 $9.25 121
2020 Q4 53,109,159 $513,580,534 -$47,148,476 $9.67 119
2020 Q3 55,543,085 $689,284,591 +$37,297,727 $12.41 122
2020 Q2 52,506,803 $683,821,623 +$177,437,307 $13.00 108
2020 Q1 39,039,096 $396,249,329 -$15,719,655 $10.15 95
2019 Q4 40,415,352 $631,689,853 -$16,734,787 $15.63 86
2019 Q3 41,336,618 $693,682,039 +$153,760,437 $16.79 78
2019 Q2 36,689,307 $812,845,961 +$18,784,299 $22.18 74
2019 Q1 35,897,641 $776,340,000 +$776,340,189 $21.67 71